Morpholino

MO2-myd88

ID
ZDB-MRPHLNO-080325-4
Name
MO2-myd88
Previous Names
None
Target
Sequence
5' - GTTAAACACTGACCCTGTGGATCAT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
splice blocker (exon2-intron2)
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-myd88
Expressed Gene Anatomy Figures
myd88 Fig. 8 from Fehr et al., 2016
Fig. S4 from Cambier et al., 2014
Phenotype
Phenotype resulting from MO2-myd88
Phenotype of all Fish created by or utilizing MO2-myd88
Phenotype Fish Conditions Figures
fourth ventricle monocyte decreased amount, abnormal AB + MO2-myd88 bacterial treatment by injection: Pseudomonas aeruginosa Fig. 1 with image from Cambier et al., 2017
fourth ventricle monocyte decreased amount, abnormal AB + MO2-myd88 bacterial treatment by injection: Staphylococcus aureus Fig. 1 with image from Cambier et al., 2017
fourth ventricle monocyte chemotaxis decreased occurrence, abnormal AB + MO2-myd88 bacterial treatment by injection: Staphylococcus aureus Fig. 1 with image from Cambier et al., 2017
fourth ventricle neutrophil decreased amount, abnormal AB + MO2-myd88 bacterial treatment by injection: Staphylococcus aureus Fig. 1 with image from Cambier et al., 2017
fourth ventricle neutrophil decreased amount, abnormal AB + MO2-myd88 bacterial treatment by injection: Pseudomonas aeruginosa Fig. 1 with image from Cambier et al., 2017
fourth ventricle monocyte chemotaxis decreased occurrence, abnormal AB + MO2-myd88 bacterial treatment by injection: Pseudomonas aeruginosa Fig. 1 with image from Cambier et al., 2017
whole organism neutrophil decreased amount, abnormal WT + MO2-myd88 bacterial treatment by injection: Waddlia chondrophila WSU 86-1044 Fig. 8 from Fehr et al., 2016
posterior intestine goblet cell decreased amount, abnormal WT + MO2-myd88 control Fig. 3Fig. 4 from Troll et al., 2018
activation of innate immune response decreased process quality, abnormal WT + MO2-myd88 standard conditions Fig. 6 with image from van der Vaart et al., 2013
alkaline phosphatase activity decreased occurrence, abnormal WT + MO2-myd88 standard conditions Fig. 1 from Bates et al., 2007
intestinal bulb peptide hormone secreting cell decreased amount, abnormal WT + MO2-myd88 control Fig. 4 from Troll et al., 2018
posterior intestine goblet cell decreased amount, abnormal WT + MO2-myd88 germ free Fig. 3 from Troll et al., 2018
whole organism decreased life span, exacerbated WT + MO2-myd88 bacterial treatment by injection: Waddlia chondrophila WSU 86-1044 Fig. 8 from Fehr et al., 2016
whole organism myd88 expression decreased amount, abnormal WT + MO2-myd88 control Fig. 8 from Fehr et al., 2016
macrophage chemotaxis decreased occurrence, abnormal w201Tg + MO2-myd88 (AB) bacterial treatment by injection: Mycobacterium leprae Fig. 1 with image from Madigan et al., 2017
macrophage chemotaxis decreased occurrence, abnormal w201Tg + MO2-myd88 (AB) bacterial treatment by injection: Mycobacterium marinum Fig. 1 with image from Madigan et al., 2017
neutrophil decreased amount, abnormal hkz04tTg; nz50Tg + MO2-myd88 + MO4-myd88 amputation: caudal fin Fig. 2 from Yan et al., 2014
neutrophil chemotaxis decreased process quality, abnormal hkz04tTg; nz50Tg + MO2-myd88 + MO4-myd88 amputation: caudal fin Fig. 2Fig. 4 from Yan et al., 2014
epithelial cell proliferation increased occurrence, abnormal axin1tm213/tm213 + MO2-myd88 standard conditions Fig. 4 with image from Cheesman et al., 2011
intestinal bulb epithelium cellular quality, abnormal axin1tm213/tm213 + MO2-myd88 standard conditions Fig. 4 with image from Cheesman et al., 2011
posterior intestine goblet cell increased amount, abnormal dldtr233/tr233 + MO2-myd88 control Fig. 4 from Troll et al., 2018
intestinal bulb peptide hormone secreting cell amount, ameliorated b1390Tg + MO2-myd88 control Fig. 4 from Troll et al., 2018
cell autophagosome decreased amount, abnormal zf155Tg + MO2-myd88 bacterial treatment: Mycobacterium marinum Fig. 6 with image from van der Vaart et al., 2014
neutrophil decreased amount, abnormal hkz04tTg; nz50Tg + MO2-myd88 + MO3-il1b + MO4-myd88 amputation: caudal fin Fig. 2 from Yan et al., 2014
neutrophil chemotaxis decreased process quality, abnormal hkz04tTg; nz50Tg + MO2-myd88 + MO3-il1b + MO4-myd88 amputation: caudal fin Fig. 2 from Yan et al., 2014
Citations